Which of the following companies started selling humulin in the year 1...
Answer:
Eli Lilly is the company that started selling Humulin in the year 1983.
Explanation:
Humulin is a type of insulin used to treat diabetes, and it was the first genetically engineered drug to be approved by the US Food and Drug Administration (FDA). The development of Humulin was a joint effort between Eli Lilly and Genentech, but Eli Lilly was the company responsible for marketing and selling the drug.
The approval of Humulin in 1982 marked a significant milestone in the field of biotechnology and paved the way for the development of more genetically engineered drugs. Eli Lilly has since continued to be a major player in the diabetes market, developing and marketing other insulin products such as Humalog and Basaglar.
In summary, Eli Lilly started selling Humulin in the year 1983, making it the first genetically engineered drug to be marketed and sold to the public.
Which of the following companies started selling humulin in the year 1...
In 1983, Eli Lilly an American company, first prepared two DNA sequences corresponding to A and B chains of human insulin and introduced them in plasmids of Escherichia coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulphide bonds to form human insulin (humulin).